HomeComparePPBI vs MRK

PPBI vs MRK: Dividend Comparison 2026

PPBI yields 5.39% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PPBI wins by $931.7K in total portfolio value
10 years
PPBI
PPBI
● Live price
5.39%
Share price
$24.49
Annual div
$1.32
5Y div CAGR
50.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.5K
Annual income
$613,145.25
Full PPBI calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PPBI vs MRK

📍 PPBI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPPBIMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PPBI + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PPBI pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PPBI
Annual income on $10K today (after 15% tax)
$458.15/yr
After 10yr DRIP, annual income (after tax)
$521,173.46/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, PPBI beats the other by $512,845.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PPBI + MRK for your $10,000?

PPBI: 50%MRK: 50%
100% MRK50/50100% PPBI
Portfolio after 10yr
$522.6K
Annual income
$311,471.70/yr
Blended yield
59.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PPBI
Analyst Ratings
6
Buy
8
Hold
Consensus: Hold
Price Target
$32.67
+33.4% upside vs current
Range: $26.00 — $41.00
Altman Z
-0.6
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PPBI buys
6
MRK buys
0
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PPBI▼ Sell$1,001 - $15,0002025-09-03
Gilbert Cisneros🏢 House$PPBI▼ Sell$1,001 - $15,0002025-06-16
Josh Gottheimer🏢 House$PPBI▼ Sell$1,001 - $15,0002025-03-19
Josh Gottheimer🏢 House$PPBI▲ Buy$1,001 - $15,0002024-10-17
Josh Gottheimer🏢 House$PPBI▼ Sell$1,001 - $15,0002024-09-16
Josh Gottheimer🏢 House$PPBI▲ Buy$1,001 - $15,0002024-07-19
Josh Gottheimer🏢 House$PPBI▼ Sell$1,001 - $15,0002024-06-18
Gilbert Cisneros🏢 House$PPBI▲ Buy$1,001 - $15,0002020-10-29
Josh Gottheimer🏢 House$PPBI▲ Buy$1,001 - $15,0002020-10-16
Josh Gottheimer🏢 House$PPBI▼ Sell$1,001 - $15,0002020-09-15
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPPBIMRK
Forward yield5.39%2.76%
Annual dividend / share$1.32$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR50.5%32.7%
Portfolio after 10y$988.5K$56.8K
Annual income after 10y$613,145.25$9,798.13
Total dividends collected$927.4K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$32.67$128.54

Year-by-year: PPBI vs MRK ($10,000, DRIP)

YearPPBI PortfolioPPBI Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,511$811.19$11,206$366.19+$305.00PPBI
2$13,630$1,313.39$12,650$502.35+$980.00PPBI
3$16,772$2,187.43$14,407$694.19+$2.4KPPBI
4$21,732$3,785.84$16,585$967.82+$5.1KPPBI
5$30,153$6,899.67$19,342$1,363.89+$10.8KPPBI
6$45,729$13,465.16$22,913$1,947.19+$22.8KPPBI
7$77,652$28,722.70$27,662$2,823.89+$50.0KPPBI
8$151,691$68,603.25$34,159$4,173.35+$117.5KPPBI
9$350,806$188,496.65$43,337$6,308.80+$307.5KPPBI
10$988,508$613,145.25$56,776$9,798.13+$931.7KPPBI

PPBI vs MRK: Complete Analysis 2026

PPBIStock

Pacific Premier Bancorp, Inc. operates as the bank holding company for Pacific Premier Bank that provides banking services to businesses, professionals, real estate investors, and non-profit organizations. The company accepts deposit products, such as checking, money market, and savings accounts; and certificates of deposit. Its loan portfolio includes commercial real estate owner and non-owner-occupied, multifamily, construction and land, franchise real estate secured, small business administration (SBA), and SBA paycheck protection program loans; revolving lines or credit, term loans, seasonal loans, and loans secured by liquid collateral; one-to-four family and home equity lines of credit loans; and savings account secured loans and auto loans. The company also offers cash management, electronic banking, treasury management, and online bill payment services. It operates 61 full-service depository branches located in Arizona, California, Nevada, Oregon, and Washington. Pacific Premier Bancorp, Inc. was founded in 1983 and is headquartered in Irvine, California.

Full PPBI Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PPBI vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PPBI vs SCHDPPBI vs JEPIPPBI vs OPPBI vs KOPPBI vs MAINPPBI vs JNJPPBI vs ABBVPPBI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.